trifectUserMessage

billToLabel

nonTrifectaUserMessage

requireAuthentication

unValidatedMessage

unregisteredMessage

requireRegistration

requiresValidation

unauthenticatedMessage

siteLink

siteLogo

headerLinks

Header Links

parentCompanyLink

mainSiteLink

footerLinks

Footer Links

copyrights

opcoLogos

Opco Logos

trademarks

parentCompanyLogo

mainSiteLinkText

regulatory

siteRobotsTXT

gtmId

footerGTMScript

headerGTMScript

Content Source Notes

MAPSS Code

Alert banners

isExternal

description

title

style

checkCommerceEnabled

Copyright

Legal

Online Terms of Use

Patents

Privacy Statement

Sitemap

Danaher Life Sciences

Dashboard

Quotes

Scheduled Orders

Order History

order-center

redeemQuotePage

The CD86 antigen (B7-2, B70) is a single-chain trans-membrane glycoprotein, structurally similar to CD80. Its molecular weight is 80 kDa, under reducing conditions. The extracellular region is composed of one V-type and one C-type Ig-like domains. There are 8 potential sites for N-glycosylation. The cytoplasmic tail has 3 potential sites for protein kinase C phosphorylation. CD86 shares with the CD80 molecule the same co-receptors on T cells, CD28 and CD152 (CTLA-4). CD86 binds to CD152 with a 20-100-fold higher affinity than to CD28. CD86 is expressed constitutively by interdigitating dendritic cells, and at lower level by peripheral blood dendritic cells. It is strongly expressed by monocytes. On lymphocytes, CD86 appears as a B-cell activation antigen. CD86 is preferentially expressed by memory B cells and germinal center B cells, but not on plasma cells. Its expression can be up-regulated by activation through surface immunoglobulin, CD40, MHC class II molecules or by PMA with ionomycin. T cells activated by CD3 ligation have also been reported to express CD86.

The CD86 antigen (B7-2, B70) is a single-chain trans-membrane glycoprotein, structurally similar to CD80. Its molecular weight is 80 kDa, under reducing conditions. The extracellular region is composed of one V-type and one C-type Ig-like domains. There are 8 potential sites for N-glycosylation. The cytoplasmic tail has 3 potential sites for protein kinase C phosphorylation. CD86 shares with the CD80 molecule the same co-receptors on T cells, CD28 and CD152 (CTLA-4). CD86 binds to CD152 with a 20-100-fold higher affinity than to CD28. CD86 is expressed constitutively by interdigitating dendritic cells, and at lower level by peripheral blood dendritic cells. It is strongly expressed by monocytes. On lymphocytes, CD86 appears as a B-cell activation antigen. CD86 is preferentially expressed by memory B cells and germinal center B cells, but not on plasma cells. Its expression can be up-regulated by activation through surface immunoglobulin, CD40, MHC class II molecules or by PMA with ionomycin. T cells activated by CD3 ligation have also been reported to express CD86.

*Alexa Fluor and Pacific Blue are registered trademarks of Molecular Probes, Inc.

B30646, CD86-APC-Alexa Fluor 750 Conjugated Antibody, HA5.2B7, 0.5 mL, ASR

The CD86 antigen (B7-2, B70) is a single-chain trans-membrane glycoprotein, structurally similar to CD80. Its molecular weight is 80 kDa, under reducing conditions. The extracellular region is composed of one V-type and one C-type Ig-like domains.

Learn more about this product on Beckman.com

CD86-APC-Alexa Fluor 750, HA5.2B7, 0.5 mL, ASR